James Budge Sells 5,906 Shares of Hinge Health (NYSE:HNGE) Stock

Hinge Health Inc. (NYSE:HNGE) CFO James Budge sold 5,906 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $54.82, for a total value of $323,766.92. Following the completion of the transaction, the chief financial officer owned 386,293 shares in the company, valued at approximately $21,176,582.26. This trade represents a 1.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Budge also recently made the following trade(s):

• On Monday, March 23rd, James Budge sold 11,006 shares of Hinge Health stock. The stock was sold at an average price of $42.26, for a total value of $465,113.56.

Hinge Health Stock Performance

Shares of Hinge Health stock opened at $54.00 on Thursday. Hinge Health Inc. has a one year low of $30.08 and a one year high of $62.18. The stock’s fifty day moving average is $43.77 and its 200 day moving average is $44.15. The stock has a market cap of $4.25 billion and a P/E ratio of -4.38.

Hinge Health (NYSE:HNGE) last announced its earnings results on Tuesday, May 5th. The company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.33. The company had revenue of $182.31 million for the quarter. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.Hinge Health’s revenue for the quarter was up 47.2% compared to the same quarter last year. During the same period in the prior year, the business posted $1.30 earnings per share. Analysts predict that Hinge Health Inc. will post 0.78 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Wells Fargo & Company MN boosted its position in shares of Hinge Health by 160.0% during the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock valued at $25,000 after buying an additional 336 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in shares of Hinge Health during the fourth quarter valued at approximately $26,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Hinge Health during the third quarter valued at approximately $37,000. First Horizon Corp boosted its position in shares of Hinge Health by 163.9% during the fourth quarter. First Horizon Corp now owns 855 shares of the company’s stock valued at $40,000 after buying an additional 531 shares during the period. Finally, CENTRAL TRUST Co purchased a new position in shares of Hinge Health during the first quarter valued at approximately $37,000.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on HNGE. Citizens Jmp lifted their target price on Hinge Health from $65.00 to $80.00 and gave the stock a “market outperform” rating in a report on Wednesday, May 6th. Canaccord Genuity Group lifted their target price on Hinge Health from $53.00 to $63.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Truist Financial set a $79.00 target price on Hinge Health in a report on Wednesday, May 6th. Weiss Ratings raised Hinge Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, May 6th. Finally, Evercore reiterated an “outperform” rating and issued a $45.00 price target on shares of Hinge Health in a research report on Wednesday, April 8th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $67.40.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.